Clinical Trial Update: Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating switching from twice-daily to once-daily clozapine dosing in schizophrenia and schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: RECRUITING